Technology | August 09, 2013

Compass provides needed flexibility for optimal QA efficiency enabling measurement as well as full 3-D calculation-based independent treatment plan verification

IBA Launches Compass Two-in-One Radiation Therapy Plan Verification System

August 9, 2013 — IBA (Ion Beam Applications S.A) has launched its Compass 3.0 plan verification system. Compass, the first patient anatomy-centric and solution for advanced intensity-modulated radiotherapy (IMRT) and rotational plan verification now provides a new two-in-one solution: calculation-based, full 3-D independent treatment plan system (TPS) verification and measurement-based quality assurance (QA) for the complete treatment chain, including linear accelerators.

Compass offers full workflow flexibility, allowing physicists and dosimetrists to choose the most efficient QA for any clinical need.

The new Compass also provides crucial calculation time saving and therefore much faster QA workflows. Dose calculations of 7 beam IMRT plans are done in just one minute, and more sophisticated 1 arc volumetric modulated arc therapy (VMAT) plans in just over two minutes.

With its powerful collapsed cone algorithm for independent dose calculations, Compass allows TPS-class dose calculations on real patient computed tomography (CT) as well as real patient CT-based DVH, and 3-D Gamma.

Independent beam modeling of individual linacs enables flexibility in precisely modeling as many machines as needed for highly accurate plan verifications. Physicists can measure and compare real linac delivery versus TPS-planned delivery as well as analyze the effect of segment errors on the total treatment accuracy. Plan verification is a step in radiation therapy to ensure treatment accuracy and patient dose safety.

For more information: www.iba-dosimetry.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now